Wanbury Limited — Important, 09-01-2025: General Updates

Wanbury Limited has made significant additions to its Board of Directors with the appointment of Mr. Pallavur Sankar Dass Vaidyanathan and Mr. Manoj Gursahani as Non-Executive Independent Directors. Mr. Vaidyanathan brings extensive experience from his previous role as CEO of Curatio Healthcare, where he successfully scaled the business and led its divestment to Torrent Pharma. His 35 years in the pharma industry, including senior roles at Dr. Reddy’s Lab, is expected to provide strategic leadership.

Mr. Gursahani complements the board with his entrepreneurial background as the Co-Founder of Vera Healthcare Technologies and involvement in various trusts and chambers. His diverse expertise in healthcare technology and strategy enhances the company's governance ahead of the extraordinary meeting scheduled for February 20, 2025, where shareholder approval for these appointments will be sought. These additions suggest a positive outlook for Wanbury, bringing in leadership capable of navigating the evolving healthcare landscape.